These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 17940339

  • 21. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model.
    Jin J, Teng G, Feng Y, Wu Y, Jin Q, Wang Y, Wang Z, Lu Q, Jiang Y, Wang S, Chen F, Marchal G, Ni Y.
    Cardiovasc Intervent Radiol; 2007; 30(2):248-56. PubMed ID: 17216375
    [Abstract] [Full Text] [Related]

  • 22. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B, Freund M, Ravanat C, Magnenat S, Cazenave JP, Gachet C.
    Circulation; 2008 Aug 12; 118(7):754-63. PubMed ID: 18663083
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X, Jackson EF, Price RE, Kim EE, Wu Q, Wallace S, Charnsangavej C, Gelovani JG, Li C.
    Bioconjug Chem; 2004 Aug 12; 15(6):1408-15. PubMed ID: 15546209
    [Abstract] [Full Text] [Related]

  • 24. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
    Wang Y, Zhao X, Jin H, Wei H, Li W, Bu D, Tang X, Ren Y, Tang C, Du J.
    Arterioscler Thromb Vasc Biol; 2009 Feb 12; 29(2):173-9. PubMed ID: 18988885
    [Abstract] [Full Text] [Related]

  • 25. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
    Sirol M, Fuster V, Badimon JJ, Fallon JT, Moreno PR, Toussaint JF, Fayad ZA.
    Circulation; 2005 Sep 13; 112(11):1594-600. PubMed ID: 16145001
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug.
    Sonoda A, Nitta N, Ohta S, Nitta-Seko A, Murata S, Jo J, Tabata Y, Takahashi M, Tani T, Murata K.
    J Magn Reson Imaging; 2009 Oct 25; 30(4):907-10. PubMed ID: 19787744
    [Abstract] [Full Text] [Related]

  • 31. In vivo MR imaging of bone marrow cells trafficking to atherosclerotic plaques.
    Qiu B, Gao F, Walczak P, Zhang J, Kar S, Bulte JW, Yang X.
    J Magn Reson Imaging; 2007 Aug 25; 26(2):339-43. PubMed ID: 17623878
    [Abstract] [Full Text] [Related]

  • 32. In vivo MR detection of vascular endothelial injury using a new class of MRI contrast agent.
    Yamamoto T, Ikuta K, Oi K, Abe K, Uwatoku T, Hyodo F, Murata M, Shigetani N, Yoshimitsu K, Shimokawa H, Utsumi H, Katayama Y.
    Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2787-90. PubMed ID: 15125933
    [Abstract] [Full Text] [Related]

  • 33. A comparative evaluation of CH3-DTPA-Gd (NMS60) for contrast-enhanced magnetic resonance angiography.
    Bammer R, de Crespigny AJ, Howard D, Seri S, Hashiguchi Y, Nakatani A, Moseley ME.
    Magn Reson Imaging; 2004 Jun 07; 22(5):619-24. PubMed ID: 15172054
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles.
    Michalska M, Machtoub L, Manthey HD, Bauer E, Herold V, Krohne G, Lykowsky G, Hildenbrand M, Kampf T, Jakob P, Zernecke A, Bauer WR.
    Arterioscler Thromb Vasc Biol; 2012 Oct 07; 32(10):2350-7. PubMed ID: 22879583
    [Abstract] [Full Text] [Related]

  • 37. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
    Gómez M, Sanz-González SM, Abu Nabah YN, Lamana A, Sánchez-Madrid F, Andrés V.
    Cardiovasc Res; 2009 Jan 01; 81(1):197-205. PubMed ID: 18703531
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice.
    Nogueira BV, Peotta VA, Meyrelles SS, Vasquez EC.
    Arch Med Res; 2007 Nov 01; 38(8):816-21. PubMed ID: 17923260
    [Abstract] [Full Text] [Related]

  • 39. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease.
    Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M, Weissleder R.
    Circulation; 2007 Jan 23; 115(3):377-86. PubMed ID: 17224478
    [Abstract] [Full Text] [Related]

  • 40. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice.
    Foteinos G, Hu Y, Xiao Q, Metzler B, Xu Q.
    Circulation; 2008 Apr 08; 117(14):1856-63. PubMed ID: 18378610
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.